Drug application
SYNALGOS-DC (ASPIRIN, CAFFEINE, DIHYDROCODEINE BITARTRATE)
Drugs@FDA NDA 011483 · SUN PHARM INDUSTRIES
Key facts
| Drug name | SYNALGOS-DC |
|---|---|
| Active ingredients | ASPIRIN, CAFFEINE, DIHYDROCODEINE BITARTRATE |
| Application type | NDA |
| Application number | 011483 |
| Company | SUN PHARM INDUSTRIES |
| Dosage forms | CAPSULE, ORAL |
| Strength | 356.4MG;30MG;16MG |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Jul 7, 1958 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 10–99 Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: